Literature DB >> 13952555

Distribution and metabolism of salicyl-azo-sulfapyridine. I. A study with C-14-5-amino-salicylic acid.

A HANNGREN, E HANSSON, N SVARTZ, S ULLBERG.   

Abstract

Entities:  

Keywords:  AMINOSALICYLIC ACID; CONNECTIVE TISSUE; INTESTINES; LIVER; SULFONAMIDES

Mesh:

Substances:

Year:  1963        PMID: 13952555     DOI: 10.1111/j.0954-6820.1963.tb16506.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


× No keyword cloud information.
  11 in total

1.  Salicylazosulfapyridine in inflammatory bowel disease.

Authors:  K M Das; I Sternlieb
Journal:  Am J Dig Dis       Date:  1975-10

Review 2.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

3.  Whole body sagittal technique in mice employing a new bio-autographic method: its utility for the evaluation of the body distribution of antibacterial drugs.

Authors:  E Tubaro; M J Bulgini
Journal:  Experientia       Date:  1967-04-15

4.  Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.

Authors:  B West; R Lendrum; M J Hill; G Walker
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

Review 5.  Clinical pharmacokinetics of sulphasalazine.

Authors:  K M Das; R Dubin
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

6.  Nephrotoxic lesions from 5-aminosalicylic Acid.

Authors:  I C Calder; C C Funder; C R Green; K N Ham; J D Tange
Journal:  Br Med J       Date:  1972-01-15

Review 7.  Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

8.  The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man.

Authors:  A K Azadkhan; S C Truelove; J K Aronson
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

9.  Inhibition of neutral proteases from polymorphonuclear (PMN) neutrophils by salicylazosulfapyridine (SASP).

Authors:  C Klessen
Journal:  Histochemistry       Date:  1980

10.  Modulation of cisplatin cytotoxicity by sulphasalazine.

Authors:  S Awasthi; R Sharma; S S Singhal; N K Herzog; M Chaubey; Y C Awasthi
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.